I titled yesterday’s post, “Medical Update On Two “Tumor Buddies.” I reported on my dog, Finnegan’s, surgery to remove a large tumor in his rear right leg. I never got around to writing about my latest complication–a possible lesion(s) in my right hip and lots of fluid in that same joint.
I started experiencing intermittent leg pain around Christmas. At one point, it got so bad I could barely walk. So Pattie and a good friend named Karl insisted I head on in to Moffitt Cancer Center and have them take a look.
Doctors there suspected a plasmacytoma, or soft tumor in the muscle. Instead, a MRI revealed a new “hole” or likely lesion in my hip. It also showed fluid in the joint. Here is what the radiology report revealed after I went back–once again–for follow-up x-rays:
EVALUATION, RIGHT MEDIAL PROXOMAL THIGH MASS
Findings: No focal masses identified. There is a moderate to large right and small left hip join effusion. Abnormal signal is seen in the junction of the ischium and posterior column of the right acetabulum, measuring up to 2.3 x 1.1 x1.7cm. In a patient with history of multiple myeloma, this is worrisome for a myelomatous deposit. There is degenerative change of the hips.
OK. Best I can tell (It has been a long, long time since I took anatomy!) that means the hole is in the lower/rear part of the hip bone.
The fluid is interesting… Someone at the clinic described it as being like a “myeloma soup.” I will get confirmation today. The pain makes some sense now. I think much of it is caused by the fluid being compressed and having no where to go. All other pain is in my femur, which doesn’t make sense according to this report.
As a funny aside, I have always been told using contrast in an MRI is contraindicated for someone with multiple myeloma. The tech argued with me at the time, but the radiologist on duty confirmed this can be an issue by phone. So the fact I refused contrast is plastered all over my report.
The report ends this way:
Contrast administration was withheld over patient concerns for gadolinium administration. If clinical suspicion persists and the patient was (is) cleared clinically for contrast administration, a contrast only examination can be performed.
Let me close by adding that apparently, the location of this new lesion makes it difficult to biopsy. Good news: I probably won’t need a surgical biopsy, being on warfarin and–well–just the pain and inconvenience of the whole thing. Bad news: It makes it more difficult to confirm there are active myeloma cells there.
Hey–fellow myeloma patients–isn’t this fun? I will let everyone know what Dr. Cheong has to say tomorrow.
Feel good and keep smiling! Pat